Summary
The pharmacokinetic behavior and bioavailability of paeonol were determined after a single intramuscular (i.m.) injection of 10 mg/kg to rats. Plasma paeonol concentrations were measured by high performance liquid chromatography (HPLC). The main pharmacokinetic parameters were as follows: mean elimination half-life (t1/2z) 59.85±10.23 min, time to reach peak concentration (Tmax) 7.50±2.74 min, maximum concentration (Cmax) 0.71±0.13 mg/1, total body clearance (CLz) 0.24±0.03 l/min/kg, the area under concentration-time curve from 0 to 4 h (AUC0–4h) 39.01±5.69 mg/l·min, the area under concentration-time curve from 0 to infinity (AUC0−∞) 43.06±6.10 mg/1·min. The absolute bioavailability of paeonol after i.m. administration amounted to 68.68%.
Similar content being viewed by others
References
Zhang L.H., Xiao P.G., Huang Y., Qian Y.K. (1996): Progresses in pharmacological and clinical studies of paeonol. Zhongguo Zhong Xi Yi Jie He ZaZhi, 16, 187–190.
Harada M., Yamashita A., Aburada M. (1972): Pharmacological studies on the root bark of Paeonia moutan. II. Anti-inflammatory effect, preventive effect on stress-induced gastric erosion, inhibitory effect on gastric juice secretion and other effects of paeonol. Yakugaku Zasshi, 92, 750–756.
Harada M., Yamashita A., Aburada M. (1972): Pharmacological studies on the root bark of Paeonia moutan. II. Anti-inflammatory effect, preventive effect on stress-induced gastric erosion, inhibitory effect on gastric juice secretion and other effects of paeonol. Yakugaku Zasshi, 92, 750–756.
Wu X.N., Chen H.L., Chen X.G., Hu Z.D. (2003): Determination of paeonol in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies following oral administration of Moutan cortex decoction. Biomed. Chromatogr., 17, 504–508.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ma, LY., Xu, XD., Zhang, Q. et al. Paeonol pharmacokinetics in the rat following i.m. administration. Eur. J. Drug Metabol. Pharmacokinet. 33, 133–136 (2008). https://doi.org/10.1007/BF03191109
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03191109